November 14, 2022 from 11:30 am – 12:15 pm EST
This event will explore how we might better meet the needs of patients with rheumatoid arthritis (RA) via breakthroughs in the understanding of disease pathophysiology. The objectives are:
- To educate on new research regarding cytokine and signaling pathways that are implicated in the pathophysiology of RA and its presentation
- To demonstrate how evolving our understanding of these pathways may offer insights into the difficulties in achieving better patient outcomes
- To highlight the unmet needs of patients with RA, the possible causes of the unmet needs, and how these might be tackled through biomarkers and targeted therapies
There will be an introductory presentation by chair Dr. Roy Fleischmann, followed by two disease education talks by Dr. Grace Wright and Dr. Alan Epstein.
Dr. Wright’s presentation is titled “Do different patients follow different immunopathologic pathways in the development of their RA?” She will examine the relationship between the pathophysiology of RA and its presentation, in particular the importance of key pathways and how these may offer insights into explaining patient heterogeneity in RA.
Dr. Epstein’s presentation is titled “How might an evolving knowledge of immunopathologic pathways improve outcomes for specific patients?” He will discuss the ongoing unmet needs of patients with RA, specifically the suboptimal treatment response in certain subgroups. In addition, the talk will consider preclinical RA, the role biomarkers play in the management of the disease, and touch upon how personalized medicine may help us improve outcomes for some patients.
Following the presentations, there will be a live Q&A chaired by Dr. Fleischmann where audience members will be invited to ask questions and respond to the points raised.
This program is developed and offered by GSK
This is not an official function/ event of the American College of Rheumatology These are non-promotional disease awareness sessions intended for healthcare professionals only.
Speakers:
Grace Wright
MD, PhD, Consultant rheumatologist in New York City and President of Association of Women in Rheumatology (AWIR).
NYU
New York, New York
Alan Epstein
MD, Clinical Professor of Medicine at the University of Pennsylvania School of Medicine.
He is an attending physician and chief of the rheumatology section at Pennsylvania Hospital in Philadelphia, where he has a private practice in clinical rheumatology
University of Pennsylvania School of Medicine
Professor
Pennsylvania
Dr. Grace Wright – Dr. Wright is a consultant rheumatologist in New York City. She earned her undergraduate degree from Barnard College, Columbia University, graduating magna cum laude, and earned her medical and doctorate degrees at the New York University (NYU) School of Medicine. She completed her internship, residency, and chief residency in internal medicine and a fellowship in rheumatology at the NYU Medical Center, where she then served as Clinical Associate Professor of Medicine. She is the recipient of the Helen R. Downes Award for academic distinction, and is a member of the Phi Beta Kappa and the Alpha Omega Alpha honor societies. Dr. Wright is also a Fellow of the American College of Rheumatology.
In 2014, Dr. Wright founded the Association of Women in Rheumatology (AWIR), which has since grown to over 30 local chapters throughout the United States and a number of international chapters. She has served as the President of AWIR since its inception. In 2019, Dr. Wright was recognized by the Arthritis Foundation with a Woman in Motion award.
Dr. Wright has participated in numerous clinical trials, has been published in multiple peer-reviewed journals, and is a frequent lecturer at national and international conferences on rheumatic diseases.
Dr. Alan Epstein – Dr. Epstein is a Clinical Professor of Medicine at the University of Pennsylvania School of Medicine. He is an attending physician and chief of the rheumatology section at Pennsylvania Hospital in Philadelphia, where he has a private practice in clinical rheumatology.
Dr. Epstein received his undergraduate degree from Wesleyan University in Connecticut and his medical degree from Tufts University School of Medicine. He did an internship, medical residency, and chief medical residency at Montefiore Medical Center in New York. Dr. Epstein did his rheumatology fellowship at Montefiore Medical Center and the Albert Einstein College of Medicine.
Dr. Epstein is a past president of the Philadelphia Rheumatism Society. He is a Fellow of the American College of Physicians and the American College of Rheumatology (ACR). Dr. Epstein served on the Professional Development Committee of the ACR and serves on the Affiliate Society Council of the ACR. He received the 2010 Joseph Hollander Award from the Pennsylvania chapter of the Arthritis Foundation for excellence in rheumatology.
Dr. Epstein’s past research interests have included drug-induced lupus, systemic lupus, and osteoporosis. He lectures widely in the areas of immunology, RA, psoriatic arthritis, ankylosing spondylitis, gout, osteoporosis, systemic lupus erythematosus, biosimilars, and anti-inflammatory therapy.
Email Contact Information: Jacquelyn Collins – [email protected]
This is not an official program of the American College of Rheumatology.